BioNTech's investment provides a template for UK growth, say ABPI
The latest expansion of BioNTech’s presence in the UK builds on the company’s longstanding, positive strategic relationship and experience of later-stage cancer research and development in the UK. The research will focus on genomics, oncology, infectious disease vaccines, structural biology, regenerative medicine and AI.
: “This investment is a testament to the fantastic skills, research capabilities, and scientific infrastructure we have in the UK. It is also a template for how the UK could unlock further life science sector growth by removing the barriers and roadblocks to investment.
“Big investments like this are years in the making and require both sides to have confidence that the other will deliver on their commitments. Trust is slow to build, but this deal shows it is worth the time and the risk.
“Life science companies are already the largest investors in UK R&D – but much of this comes from a handful of companies with deep UK roots. The UK has an opportunity to capture more of the global science pie if we can improve our competitive offering to the sector.”
Ends
[1] Department for Science, Innovation and Technology, £1 billion BioNTech UK investment paves way for jobs, growth and potential health breakthroughs, 20 May 2025
ABPI Press Office, T: +44 (0)20 7747 7147 (24hrs), E: [email protected]
About the Association of the British Pharmaceutical Industry (ABPI)
The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care.
We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.
In England, Scotland, Wales and Northern Ireland, we work in partnership with governments and the NHS so that patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, our members partner with healthcare professionals, academics and patient organisations to find new solutions to unmet health needs. www.abpi.org.uk
